Exon definition
Examples of Exon in a sentence
Exon Signature of witness Signature of attorney ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇.
For clarity, the Exon 44 Program will be undertaken by PROSENSA commencing at the Effective Date, whereas PROSENSA will undertake DMD Program 3 commencing within * * * * * of the Effective Date and DMD Program 4 commencing within * * * * * of the Effective Date pursuant to Section 2.5 and following payment by GSK pursuant to Section 6.2(c), provided, however, that the Parties will consider the possibility of shortening these timelines and the actual start of these Programs at the first meeting of the JSC.
Therefore the conversion might be governed by the Exon- Flor▇▇-▇▇▇ndment, which gives the federal government to review the conversion of the preferred stocks.
TOKAI wishes to have QIAGEN develop and commercialize a companion diagnostic to identify patients carrying Androgen Receptor Exon 9 Xq12 (AR-V7) splice variant in Castration Resistant Prostate Cancer (CRPC) for treatment with the TOKAI Compound (for purposes of this Schedule, the “QIAGEN IVD”).
Exon 8 encodes a 15 amino acid portion of the cytoplasmic domain, including a cluster of six positively charged amino acids.
Following GSK’s exercise of an Option with respect to a PROSENSA Collaboration Program, and as of the Effective Date for the Exon 51 Program, as a condition for GSK maintaining the licenses granted to GSK under Article 4 with respect to a GSK Development Program, GSK shall use its Commercially Reasonable Efforts to Develop and commercialize * * * * * from such GSK Development Program as a GSK Product in the * * * * *.
Exon Name of witness (print) Name of attorney (print) UG MANUFACTURING CO.
Exon 9 encodes the remaining 13 amino acids of the cytoplasmic domain, the stop codon, and the 3’-untranslated region.
Exon Title: President & Secretary ▇▇▇▇▇▇ MANUFACTURING, INC., a California corporation, as a Domestic Borrower By: /s/ ▇▇▇▇▇▇▇ ▇.
Except as provided for herein, GSK shall have the final decision-making authority for all aspects of the Research, Development and commercialization of all Compounds and Products under the Exon 51 Program, including, PRO051, subject only to the limited rights of PROSENSA to participate in certain limited activities, as expressly set forth in Section 2.4(i) and subject to PROSENSA’s rights as expressly stated under Section 5.2, subject to GSK’s sole decision-making authority.